UNSPSC 51281815: Carubicin hydrochloride

This classification denotes the hydrochloride form of an anthracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7437K3983. European Medicines Agency schedules Carubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06151MIG. Carubicin generally arises in the molecular formula C26H27NO10.

UNSPSC 51281815 Carubicin hydrochloride is a Commodity code nominally identifying a specific chemotherapy agent, but the recent opportunities posted under it show little direct activity in that pharmaceutical product. Instead, the code has been applied to broader health-supply and pharmaceutical-procurement solicitations that do not feature carubicin as a line item or focus. State and local buying under this code designation spans emergency medical supplies, naloxone distribution programs, generic pharmaceutical contracting through cooperative purchasing vehicles, and exploratory market research for direct-to-manufacturer pharmacy initiatives. The issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP serving Minnesota and Oregon). No vendor repeat-buyers or standout concentration pattern emerges from the limited recent record.

Geographic activity centers on Florida, Texas, and Minnesota–Oregon through the MMCAP cooperative. Seminole County, Florida posted IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa posted ITB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies—respiratory equipment, cardiac monitors, endotracheal tubes, gloves, and oxygen delivery systems—for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount for certified Small Local Business Enterprises. The Texas Health and Human Services Commission issued RFI HHS0017013 (due April 3, 2026) to gather vendor market intelligence on implementing a Therapeutic Pharmacy Initiative for direct-to-manufacturer prescription contracts outside traditional pharmacy benefit manager arrangements. MMCAP posted RFP S1070000015802 (due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with contract terms effective July 1, 2026. The code shows limited recent activity directly tied to carubicin procurement; opportunities are broadly distributed across emergency medical supplies, naloxone, generic pharmaceuticals, and pharmacy program innovation rather than the specific drug indicated by the code number.